Variant report
Variant | esv3403820 |
---|---|
Chromosome Location | chr8:9083542-9087740 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr8:9087660-9087810 | GM12872 | blood: | n/a | n/a |
2 | CUX1 | chr8:9087199-9087210 | K562 | blood: | n/a | n/a |
3 | MAFK | chr8:9085828-9085958 | HepG2 | liver: | n/a | n/a |
4 | MAFK | chr8:9087514-9087608 | HepG2 | liver: | n/a | n/a |
5 | MAFK | chr8:9087503-9087639 | HepG2 | liver: | n/a | n/a |
6 | MAX | chr8:9085656-9085749 | HepG2 | liver: | n/a | chr8:9085661-9085671 |
7 | MAX | chr8:9085594-9085823 | H1-hESC | embryonic stem cell: | n/a | chr8:9085639-9085649 chr8:9085661-9085671 chr8:9085649-9085659 |
8 | MAX | chr8:9085574-9085826 | NB4 | blood: | n/a | chr8:9085639-9085649 chr8:9085661-9085671 chr8:9085649-9085659 |
9 | MYC | chr8:9085792-9085795 | K562 | blood: | n/a | n/a |
10 | RFX5 | chr8:9084600-9084634 | Hela-S3 | cervix: | n/a | n/a |
11 | SUZ12 | chr8:9085496-9085775 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | USF2 | chr8:9085547-9085652 | HepG2 | liver: | n/a | n/a |
13 | USF2 | chr8:9085663-9085679 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-10A14.4.1-6 | chr8:9084120-9084517 | l_3543_chr8:9084119-9097777_placenta |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254091 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567761772 | chr8:9083555-9083556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs62496288 | chr8:9083563-9083564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116997024 | chr8:9083580-9083581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2929310 | chr8:9083589-9083590 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs541437508 | chr8:9083609-9083610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576894413 | chr8:9083619-9083620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76814296 | chr8:9083629-9083630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146284654 | chr8:9083638-9083639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556355942 | chr8:9083639-9083640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576282067 | chr8:9083655-9083656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139388414 | chr8:9083670-9083671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561954285 | chr8:9083694-9083695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566309952 | chr8:9083761-9083762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2929309 | chr8:9083771-9083772 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs936647 | chr8:9083779-9083780 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs551676837 | chr8:9083809-9083810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549620144 | chr8:9083811-9083812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560256918 | chr8:9083825-9083826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141179405 | chr8:9083833-9083834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2929454 | chr8:9083854-9083855 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs79669058 | chr8:9083881-9083882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35545979 | chr8:9083885-9083886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs118111396 | chr8:9083957-9083958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115359858 | chr8:9083966-9083967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs80024049 | chr8:9083981-9083982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568417987 | chr8:9084046-9084047 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534199795 | chr8:9084068-9084069 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574858788 | chr8:9084075-9084076 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547385933 | chr8:9084079-9084080 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570334956 | chr8:9084092-9084093 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544773814 | chr8:9084104-9084105 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2929308 | chr8:9084121-9084122 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs144122468 | chr8:9084123-9084124 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs563137768 | chr8:9084124-9084125 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs77494852 | chr8:9084148-9084149 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs535653002 | chr8:9084155-9084156 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs540844215 | chr8:9084165-9084166 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs572389629 | chr8:9084181-9084182 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs192390182 | chr8:9084215-9084216 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs2929307 | chr8:9084228-9084229 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs7836473 | chr8:9084229-9084230 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs546322175 | chr8:9084257-9084258 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs536534327 | chr8:9084274-9084275 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs62496289 | chr8:9084277-9084278 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs542041114 | chr8:9084292-9084293 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs529915895 | chr8:9084329-9084330 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs2929453 | chr8:9084341-9084342 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs184623778 | chr8:9084375-9084376 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs373608555 | chr8:9084398-9084399 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs528404825 | chr8:9084409-9084410 | Weak transcription Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:9079200-9088000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr8:9080800-9084000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr8:9081000-9083600 | Enhancers | HMEC | breast |
4 | chr8:9081000-9085400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr8:9081200-9084000 | Enhancers | Aorta | Aorta |
6 | chr8:9081200-9084400 | Enhancers | Osteobl | bone |
7 | chr8:9081400-9084200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr8:9082800-9088000 | Weak transcription | Brain Substantia Nigra | brain |
9 | chr8:9082800-9088600 | Weak transcription | Brain Cingulate Gyrus | brain |
10 | chr8:9083000-9087800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr8:9083000-9087800 | Weak transcription | Brain Hippocampus Middle | brain |
12 | chr8:9083000-9087800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
13 | chr8:9083200-9087200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
14 | chr8:9083200-9090200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:9084000-9084200 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr8:9084000-9084400 | Weak transcription | Aorta | Aorta |
17 | chr8:9084200-9084400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr8:9084400-9084600 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr8:9084400-9084600 | Flanking Active TSS | Osteobl | bone |
20 | chr8:9084400-9085000 | Enhancers | Aorta | Aorta |
21 | chr8:9084600-9085000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr8:9085000-9088000 | Weak transcription | Aorta | Aorta |
23 | chr8:9085400-9085600 | Weak transcription | H9 Cell Line | embryonic stem cell |
24 | chr8:9085400-9086200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
25 | chr8:9086400-9086600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
26 | chr8:9087000-9088000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
27 | chr8:9087000-9088200 | Enhancers | Fetal Brain Male | brain |
28 | chr8:9087200-9088000 | Enhancers | Cortex derived primary cultured neurospheres | brain |